Stockscreener 앱 받기
1.57
6.08%
0.09
시장 영업 전:
1.58
0.01
+0.64%
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SXTP|60 Degrees Pharmaceuticals Inc|Price:1.580|Chg%:+0.100 - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals (SCTP) Proxy filing Summary - Quartr
60 Degrees Pharmaceuticals (SCTP) Registration Filing Summary - Quartr
60 Degrees Pharmaceuticals: FDA-Approved Malaria & Babesiosis Treatments, Clinical Pipeline, and Commercial Growth (2026 Investor Update) – Minichart - Minichart
60 Degrees updates strategy for ARAKODA and profitability - TipRanks
Frontier tech research, news & data - MLQ.ai
Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals, Inc. Warranton 60 Degrees Ph Financial Disclosures & SEC Filings - TradingView
Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals (NASDAQ: SXTP) Files 8-K Report Detailing Company Updates and Security Information - Minichart
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
Interim Trial Plan Finalized for Tafenoquine Babesiosis Study - TipRanks
60 Degrees Pharmaceuticals readies interim analysis plan for tafenoquine babesiosis trial - TradingView
60 Degrees Pharmaceuticals (SXTP) sets tafenoquine babesiosis interim analysis and sNDA path - Stock Titan
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals to Advance Castanospermine for Tick-Borne Diseases Through Florida State University Deal - Moomoo
60 Degrees Pharma gets option to pursue tick-borne disease drug - Stock Titan
60 Degrees Pharmaceuticals Announces Exclusive Option - GlobeNewswire
Price to sales forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
Enterprise value to EBIT forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView
SXTP | 60 Degrees Pharmaceuticals, Inc. Executive Compensation - Quiver Quantitative
SXTPW | 60 Degrees Pharmaceuticals, Inc. Executive Compensation - Quiver Quantitative
Equity plan hike and reverse split up for 60 Degrees (SXTP) shareholder vote - Stock Titan
60 Degrees Pharma babesiosis study clears safety review - Investing.com UK
60 Degrees Pharma babesiosis study clears safety review By Investing.com - Investing.com Nigeria
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue - Yahoo Finance Singapore
SXTP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SXTP Forecast — Price Target — Prediction for 2027 - TradingView
60 Degrees Pharmaceuticals, Inc. Actuals & Estimates (BOATS:SXTP) - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Price to sales forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to EBIT forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Analysts Offer Insights on Healthcare Companies: Galectin Therapeutics (GALT) and Gilead Sciences (GILD) - The Globe and Mail
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Number of shareholders of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
SXTP News | 60 DEGREES PHARMA INC (NASDAQ:SXTP) - ChartMill
60 Degrees Pharmaceuticals Inc (SXTP) Institutional Confidence - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Institutional Confidence - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Valuation: PE, PB & Fair Value Analysis - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Top Executive Makes Bold Move With Fresh Buy in Pharma Stock - TipRanks
1.97%
0.83%
자본화:
|
볼륨(24시간):